MUC16 and neoplasm: Currently, there are several tumor biomarkers: carbohydrate antigen 19-9 (CA19-9), cancer antigen 242 (CA242), carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), microRNAs, and K-RAS gene mutations.